Pure autonomic failure
A restricted Lewy body synucleinopathy or early Parkinson disease?
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
The disorder now called pure autonomic failure (PAF) was first described by Bradbury and Eggleston1 in 1925. The original report included 3 patients with chronic postural hypotension and frequent episodes of syncope, a relatively slow and unchanging pulse rate, reduced sweating, erectile dysfunction, and constipation. Although the authors speculated that failure of the autonomic nervous system produced this syndrome, it was not until 1966 that Johnson et al.2 provided neuropathologic evidence for degeneration of sympathetic preganglionic neurons in this disorder. The first neuropathologic evidence for loss of sympathetic postganglionic neurons in PAF was reported by Goodall et al.3 and elegantly confirmed by Bannister et al.,4 who found virtual absence of catecholamine fluorescence in perivascular nerve plexuses in quadriceps muscle of 2 patients with PAF.
Surprisingly, the patient with PAF reported by Johnson et al.2 (their patient 1) had typical intraneuronal Lewy bodies identical to those seen in patients with Parkinson disease (PD). This was not a coincidental finding. Following this report, several other cases of patients with PAF with detailed clinical histories and neuropathology confirmed the presence of Lewy bodies in sympathetic ganglia and distal sympathetic axons as well as in the substantia nigra or locus ceruleus. …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Differences in Age-related Retinal and Cortical Atrophy Rates in Multiple Sclerosis
Prof. Massimo Filippi and Dr. Paolo Preziosa
► Watch
Related Articles
Alert Me
Recommended articles
-
Article
Skin sympathetic fiber α-synuclein depositsA potential biomarker for pure autonomic failureVincenzo Donadio, Alex Incensi, Pietro Cortelli et al.Neurology, February 06, 2013 -
Article
Pure autonomic failurePredictors of conversion to clinical CNS involvementWolfgang Singer, Sarah E. Berini, Paola Sandroni et al.Neurology, February 15, 2017 -
Article
Predicting phenoconversion in pure autonomic failureElizabeth A. Coon, Jay N. Mandrekar, Sarah E. Berini et al.Neurology, June 16, 2020 -
Article
Survival in synucleinopathiesA prospective cohort studyDavid S. Goldstein, Courtney Holmes, Yehonatan Sharabi et al.Neurology, October 02, 2015